Ascidian Toxins with Potential for Drug Development

被引:33
|
作者
Watters, Dianne J. [1 ]
机构
[1] Griffith Univ, Sch Environm & Sci, Brisbane, Qld 4111, Australia
来源
MARINE DRUGS | 2018年 / 16卷 / 05期
关键词
secondary metabolites; bacterial symbiosis; anticancer activity; mechanism of action; MARINE NATURAL-PRODUCTS; TETRAHYDRO-BETA-CARBOLINES; LISSOCLINUM CF. BADIUM; ANTITUMOR-ACTIVITY; TOPOISOMERASE-I; CYCLIC-PEPTIDES; CANCER-CELLS; BISTRAMIDE-A; ACETYLCHOLINESTERASE INHIBITORS; ANTIPROLIFERATIVE ACTIVITY;
D O I
10.3390/md16050162
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ascidians (tunicates) are invertebrate chordates, and prolific producers of a wide variety of biologically active secondary metabolites from cyclic peptides to aromatic alkaloids. Several of these compounds have properties which make them candidates for potential new drugs to treat diseases such as cancer. Many of these natural products are not produced by the ascidians themselves, rather by their associated symbionts. This review will focus mainly on the mechanism of action of important classes of cytotoxic molecules isolated from ascidians. These toxins affect DNA transcription, protein translation, drug efflux pumps, signaling pathways and the cytoskeleton. Two ascidian compounds have already found applications in the treatment of cancer and others are being investigated for their potential in cancer, neurodegenerative and other diseases.
引用
收藏
页数:33
相关论文
共 50 条
  • [1] Drug Development Using Natural Toxins
    Lee, Gihyun
    TOXINS, 2021, 13 (06)
  • [2] Neurotoxins and pore forming toxins in sea anemones: Potential candidates for new drug development
    Wang, Zhi-Lin
    Zhang, Shu-Yi
    Hao, Shuang-Li
    Yang, Wan -Xi
    HISTOLOGY AND HISTOPATHOLOGY, 2023, 38 (01) : 9 - 28
  • [3] Spider peptide toxins as leads for drug development
    Escoubas, Pierre
    Bosmans, Frank
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (06) : 823 - 835
  • [4] Snake venom three-finger toxins and their potential in drug development targeting cardiovascular diseases
    Kini, R. Manjunatha
    Koh, Cho Yeow
    BIOCHEMICAL PHARMACOLOGY, 2020, 181
  • [5] PHARMACEUTICAL PROPERTIES OF VENOM TOXINS AND THEIR POTENTIAL IN DRUG DISCOVERY
    Kool, Jeroen
    INDONESIAN JOURNAL OF PHARMACY, 2016, 27 (01): : 1 - 8
  • [6] The Development of Toad Toxins as Potential Therapeutic Agents
    Qi, Ji
    Zulfiker, Abu Hasanat Md
    Li, Chun
    Good, David
    Wei, Ming Q.
    TOXINS, 2018, 10 (08)
  • [7] Scorpion Venom–Toxins that Aid in Drug Development: A Review
    Arijit Ghosh
    Rini Roy
    Monoswini Nandi
    Ashis Mukhopadhyay
    International Journal of Peptide Research and Therapeutics, 2019, 25 : 27 - 37
  • [8] Tissue distribution of diarrhetic shellfish toxins in ascidian Halocynthia roretzi
    Tanabe, Toru
    Chiba, Yoshiko
    Shibuya, Kazuaki
    Shoji, Michihiro
    Ouchi, Asako
    Sato, Satoko
    NIPPON SUISAN GAKKAISHI, 2020, 86 (06) : 476 - 482
  • [9] Scorpion Venom-Toxins that Aid in Drug Development: A Review
    Ghosh, Arijit
    Roy, Rini
    Nandi, Monoswini
    Mukhopadhyay, Ashis
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2019, 25 (01) : 27 - 37
  • [10] Bacterial Superantigen Toxins, CD28, and Drug Development
    Kaempfer, Raymond
    TOXINS, 2018, 10 (11):